This brand name is authorized in Nigeria.
The drug NOSDRINE PLUS contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
7AJO3BO7QN - LORATADINE
|
|
Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage. |
|
2
|
UNII
6V9V2RYJ8N - PSEUDOEPHEDRINE HYDROCHLORIDE
|
|
Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A11-100672 | Syrup | Nosdrine Plus Syrup_ SYRUP 5 mg/5 mL; 15 mg/5 mL 60 mL | Oral Syrup. Nosdrine Plus Syrup Loratadine 5mg/5ml + Pseudoephedrine Hcl 15mg,5ml Loratadine: 0.01kg, Pseudoephedrine HCL: 0.03kg, Propylene Glycol: 1.25kg, Sucrose: 2.50kg Sodium CMC: 0.02kg, Aspartame:0.02kg, Methyl Paraben: 0.01kg, Propyl Paraben: 0.002kg, Ethanol 96%: 1.125 LTS (0.8776kg) Raspberry Essence: 0.03kg, Sunset Yellow: 0.2g, Citric Acid: 0.025kg, Butylated Hydroxyanisole (BHA): 0.0019kg Purified water to: 10.00LTS Drugs Nigerian Products 60ml POM 1 12/10/2021 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria | 28/02/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R01BA52 | Pseudoephedrine, combinations | R Respiratory system → R01 Nasal preparations → R01B Nasal decongestants for systemic use → R01BA Sympathomimetics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A11-100672 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.